Navigation Links
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/12/2009

agement are forward-looking statements. Examples of such statements include, but are not limited to, statements relating to expectations with respect to the following: the ability of Transcept to successfully obtain direction from the FDA that will effectively guide Transcept in support of its plans to resubmit the Intermezzo® NDA; the ability of Transcept to resubmit the Intermezzo® NDA to the FDA with sufficient data and other content to warrant FDA approval to market the drug candidate in its intended indication; the sufficiency of Transcept cash resources to cover a range of potential additional expenses that may be required to address the issues raised by the FDA Complete Response Letter; the potential approval and timing of regulatory decisions with respect to the NDA for Intermezzo®; Intermezzo® being the first commercially available sleep aid in the United States specifically approved for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep; the ability of Transcept to obtain and maintain patent protection and regulatory exclusivity for Intermezzo®; and financial guidance with respect to general and administrative expenses and research and development expenses. Transcept may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Transcept makes, including risks related to the following: the willingness and ability of the FDA to provide reliable guidance that will enable Transcept to make decisions in support of the Intermezzo® NDA; the ability of Transc
'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
2. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
3. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
4. Transcept Pharmaceuticals to Report First Quarter 2009 Results
5. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
6. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
7. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
8. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
9. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
10. Endo Pharmaceuticals and LecTec Settle Patent Dispute
11. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... quarter and fiscal year ended June 30, 2014 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
(Date:1/15/2014)... ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research ... http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of ... orthopedic instrument industry has seen rapid development ... 3.28 billion yuan in 2006 to 9.85 billion yuan ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... Six years ago, before smartphones were a veritable cornerstone ... Michigan joined an initiative to begin using similar handheld ... prescribe medications for their patients.  Today, ... (SEMI) reports that more than 7,500 physicians in the ...
... 28, 2012 Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company ... effective treatments for women,s health and cancer, announced today ... recommended that the Phase 3 trial of Menerba (MF101) ... its clinical safety and tolerability data. Menerba is Bionovo,s ...
Cached Medicine Technology:Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 2Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 3Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 4Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 5Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 6Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 7Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 2Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 3Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 4
(Date:7/10/2014)... THURSDAY, July 10, 2014 (HealthDay News) -- Most professional ... to return to the game, a new study finds. ... players, but their rate of return after surgery to ... explained. The new study included 60 players who ... had this procedure successfully returned to play, defined as ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, ... hot flashes that often accompany menopause, new research suggests. ... of menopausal women, said Dr. Taraneh Shirazian, an assistant professor ... School of Medicine at Mount Sinai Hospital in New York ... hot flashes a day, and she added that hot flashes ...
(Date:7/10/2014)... Dennis Thompson HealthDay Reporter ... of 10 adults make use of calorie information on menus, ... according to a new U.S. study. Women in particular ... Hee Lee-Kwan, an epidemiologist with the U.S. Centers for Disease ... they used menu labeling to help choose their meal, compared ...
(Date:7/10/2014)... issues ranging from child abuse to urban street violence, ... Society for Research on Aggression (ISRA) at the Loews ... hosting the prestigious world meeting, which is held every ... to be bringing together leading scholars from more than ... about the causes, consequences and solutions to aggressive behavior," ...
(Date:7/10/2014)... the top public health concerns in the United States, ... obese as of 2012. As health problems such as ... Twitter to discuss the problem. , A new study, ... the Brown School at Washington University in St. Louis, ... to track Twitter conversations about the issue of overweight ...
Breaking Medicine News(10 mins):Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:Study looks at how Twitter can be used to address specific health issues 2
... Association (BMA) said that the financial crisis would put an end ... work part-time after childbirth. // ,This scheme comes under ... to stop the scheme and transferring the powers to the regional ... solve the financial problems faced by few of the hospitals that ...
... of smoking tobacco can be given up through watching the ... Lori Bastian, of the Duke University Medical Center in Durham. ... who is suffering from the disease. // A telephone counseling ... This extends over a period of 12 weeks which is ...
... new drug, peramivir, claimed to be a highly potent formulation ... virus has been credited with a fast-track review by the ... drug, produced by the pharmaceutical company BioCryst can be injected ... against different bird flu strains. If successful and approved we ...
... a new study. The number of people in the country who ... 1990 figure of 0.3%, according to researchers belonging to Queen's University. ... Canada for measuring obesity, and if the BMI is above 25, ... is a case of obesity. ,As per the ...
... is facing an increased threat of bird flu as new cases ... WHO Western Pacific has said though// Asian countries are planning and ... lot should have been done and should be done to prevent ... due to bird flu infection in East Asia since the re-emergence ...
... fund has lead to cancellation of subsidized flexible working for ... four years back by the Government is being rolled back// ... hospitals have also showed interest to acquisition of NHS funded ... to financial crisis. ,Last year the government hospitals ...
Cached Medicine News:Health News:New UK Policy Threatens The Flexible Working Scheme 2
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: